Pancreatic Cancer Research

ResearcherJilin UniversityNo recent work listed

Zuojia Liu

Matched on ORCID iD 0000-0002-1770-3998; OpenAlex author ID A5033367160. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 2 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers

Papers 8

  1. Targeting KRAS in PDAC: A New Way to Cure It? First author DOI 10.3390/cancers14204982↗
  2. Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future. Co-author DOI 10.3390/ijms232315031↗
  3. Spiclomazine displays a preferential anti-tumor activity in mutant KRas-driven pancreatic cancer. Co-author DOI 10.18632/oncotarget.24025↗
  4. Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling. First author DOI 10.1371/journal.pone.0155874↗
  5. A small-molecule induces apoptosis and suppresses metastasis in pancreatic cancer cells. First author DOI 10.1016/j.ejps.2012.12.023↗
  6. Selective induction of apoptosis: promising therapy in pancreatic cancer. Co-author DOI 10.2174/1381612811319120013↗
  7. Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cells. Co-author DOI 10.1159/000337103↗
  8. A potent lead induces apoptosis in pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0037841↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Wang · 6 shared papers, 2013–2022 · strength 0.77
  2. Qianyu He · 1 shared paper, 2022 · strength 0.26
  3. Xunzhe Yin · 1 shared paper, 2022 · strength 0.22
  4. Chang Li · 1 shared paper, 2022 · strength 0.22
  5. Erkang Wang · 4 shared papers, 2012–2016 · strength 0.20
  6. Dan Li · 4 shared papers, 2012–2013 · strength 0.17
  7. Xiaoyu Guo · 1 shared paper, 2018 · strength 0.12
  8. Na Guo · 1 shared paper, 2016 · strength 0.08
  9. Fenglan Niu · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.